Investigating NKAPL, a potential marker for platinum resistance, in high-grade serous ovarian cancer

被引：0
|
作者：
Schafer, Lea [1 ,2 ]
Silva, Romina [1 ,2 ]
Stewart, Gavin [1 ]
O'Toole, Sharon [3 ]
Perry, Antoinette [1 ,2 ]
机构：
[1] Univ Coll Dublin, Sch Biol & Environm Sci, Dublin, Ireland
[2] Univ Coll Dublin, Conway Inst Biomol & Biomed Res, Canc Biol & Therapeut Lab, Dublin, Ireland
[3] Trinity Coll Dublin, Obstet & Gynaecol Histopathol, Dublin, Ireland
来源：
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER | 2024年 / 34卷 / SUPPL_3期
关键词：
D O I：
10.1136/ijgc-2024-IGCS.138
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
EV019/#412
引用
收藏
页码：A92 / A93
页数：2
相关论文
共 50 条
  • [41] The role of Apela in high-grade serous ovarian cancer
    Daily, Laura R.
    Ganguly, Debolina
    Hayes, D. Neil
    Wang, Yinan
    Sims, Michelle M.
    Cheng, Jinjun
    ElNaggar, Adam C.
    Pfeffer, Lawrence M.
    CANCER RESEARCH, 2018, 78 (13)
  • [42] Drugs Repurposing in High-Grade Serous Ovarian Cancer
    Torralba, Manuel
    Farra, Rossella
    Maddaloni, Marianna
    Grassi, Mario
    Dapas, Barbara
    Grassi, Gabriele
    CURRENT MEDICINAL CHEMISTRY, 2020, 27 (42) : 7222 - 7233
  • [43] Kallistatin inhibits tumour progression and platinum resistance in high-grade serous ovarian cancer (vol 12, 125, 2019)
    Wu, Huan
    Li, Rongrong
    Zhang, Zhiwei
    Jiang, Huiyang
    Ma, Hanlin
    Yuan, Cunzhong
    Sun, Chenggong
    Li, Yingwei
    Kong, Beihua
    JOURNAL OF OVARIAN RESEARCH, 2020, 13 (01)
  • [44] Genome-wide CRISPRi screening reveals determinants of platinum sensitivity and resistance in high-grade serous ovarian cancer
    Kong, Yi Wen
    Handly, Erika D.
    Lu, Robin A.
    Bird, Molly A.
    Schilling, Hannah-Lou
    Yaffe, Samkyu P.
    Yaffe, Michael B.
    Koch, David H.
    CANCER RESEARCH, 2024, 84 (05)
  • [45] DCLK1 mediates tumor stemness and platinum resistance in high-grade serous epithelial ovarian cancer.
    Moxley, Katherine M.
    Ha, JiHee
    Andrade, Daniel
    Houchen, Courtney
    Dhanasekaran, Danny
    CLINICAL CANCER RESEARCH, 2020, 26 (13) : 66 - 67
  • [46] Consensus on the management of platinum-sensitive high-grade serous epithelial ovarian cancer in Lebanon
    Abdallah, Reem
    Atallah, David
    Bitar, Nizar
    Chahine, Georges
    Ghanem, Hady
    Ghosn, Marwan
    Kattan, Joseph
    Nasr, Fadi
    Makdessi, Joseph
    Shamseddine, Ali
    GYNECOLOGIC ONCOLOGY REPORTS, 2023, 47
  • [47] Circulating serum miRNAs predict response to platinum chemotherapy in high-grade serous ovarian cancer
    Suzuki, Kazuhiro
    Yokoi, Akira
    Matsuzaki, Juntaro
    Yoshida, Kosuke
    Yamamoto, Yusuke
    Kato, Tomoyasu
    Ishikawa, Mitsuya
    Ochiya, Takahiro
    Kajiyama, Hiroaki
    CANCER MEDICINE, 2024, 13 (22):
  • [48] Expression of hormone receptors predicts survival and platinum sensitivity of high-grade serous ovarian cancer
    Tan, Jiahong
    Song, Chunyan
    Wang, Daoqi
    Hu, Yigang
    Liu, Dan
    Ma, Ding
    Gao, Qinglei
    BIOSCIENCE REPORTS, 2021, 41 (05)
  • [49] Genetic variation in platinum-sensitive and platinum-resistant high-grade serous epithelial ovarian cancer
    Castellano, Tara
    Clark, Leslie H.
    Rashid, Naim
    Bae-Jump, Victoria
    CANCER RESEARCH, 2017, 77
  • [50] ZIP4 Is a Novel Cancer Stem Cell Marker in High-Grade Serous Ovarian Cancer
    Fan, Qipeng
    Zhang, Wen
    Emerson, Robert E.
    Xu, Yan
    CANCERS, 2020, 12 (12) : 1 - 21
12345